Intra-Cellular Therapies, Inc. ITCI

Set alert

Price alert · ITCI

All alert types
131.87 0.00 0.00%

At close · Apr 2

131.87 Day range 131.87

52-week range unavailable

YTD
+57.89%
1 year
+97.80%
Open
131.87
Prev close
131.87
Mkt cap
14.05B
Vol
16.04M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
131.87
High
131.87
Forward P/E
507.19
Beta
0.46
Short ratio
1.20
Inst. own
96.45%
Dividend
0.00
Ex-div date
50-d avg
129.34
200-d avg
93.12
1y target
132.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ITCI has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

38.03 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -116×
FY 2015: -18.5×FY 2016: -5.6×FY 2017: -6.8×FY 2018: -4.0×FY 2019: -12.8×FY 2020: -9.8×FY 2021: -15.0×FY 2022: -19.5×FY 2023: -49.1×FY 2024: -116×
FY 2015 5y median -19.5× FY 2024
P/S 12.7×
FY 2015: 21201×FY 2016: 1973×FY 2017: 2720×FY 2018: 0.0×FY 2019: 31238×FY 2020: 99.3×FY 2021: 52.0×FY 2022: 20.0×FY 2023: 14.8×FY 2024: 12.7×
FY 2015 5y median 20.0× FY 2024
P/B 7.5×
FY 2015: 4.1×FY 2016: 1.7×FY 2017: 1.5×FY 2018: 2.0×FY 2019: 9.7×FY 2020: 3.4×FY 2021: 10.2×FY 2022: 7.6×FY 2023: 11.6×FY 2024: 7.5×
FY 2015 5y median 7.6× FY 2024
P/FCF -117×
FY 2015: -18.8×FY 2016: -7.1×FY 2017: -8.2×FY 2018: -5.3×FY 2019: -14.7×FY 2020: -9.7×FY 2021: -16.4×FY 2022: -18.4×FY 2023: -55.2×FY 2024: -117×
FY 2015 5y median -18.4× FY 2024
EV/EBITDA -71.6×
FY 2015: -18.1×FY 2016: -5.2×FY 2017: -6.1×FY 2018: -3.5×FY 2019: -11.8×FY 2020: -9.6×FY 2021: -80.2×FY 2022: -18.4×FY 2023: -42.4×FY 2024: -71.6×
FY 2015 5y median -42.4× FY 2024
EV/Sales 12.2×
FY 2015: 20685×FY 2016: 1826×FY 2017: 2566×FY 2018: 0.0×FY 2019: 29844×FY 2020: 97.9×FY 2021: 280×FY 2022: 19.5×FY 2023: 14.5×FY 2024: 12.2×
FY 2015 5y median 19.5× FY 2024
FCF Yield -0.9%
FY 2015: -5.3%FY 2016: -14.0%FY 2017: -12.1%FY 2018: -19.0%FY 2019: -6.8%FY 2020: -10.3%FY 2021: -6.1%FY 2022: -5.4%FY 2023: -1.8%FY 2024: -0.9%
FY 2015 5y median -5.4% FY 2024

Profitability

Gross Margin 91.6%
FY 2015: -52.8%FY 2016: -28273.4%FY 2017: -32205.6%FY 2018: 0.0%FY 2019: -687.2%FY 2020: 91.6%FY 2021: 90.2%FY 2022: 91.8%FY 2023: 92.7%FY 2024: 91.6%
FY 2015 5y median 91.6% FY 2024
Operating Margin -17.1%
FY 2015: -115815.9%FY 2016: -35760.0%FY 2017: -41832.6%FY 2018: 0.0%FY 2019: -254090.5%FY 2020: -1026.3%FY 2021: -349.6%FY 2022: -105.8%FY 2023: -34.3%FY 2024: -17.1%
FY 2015 5y median -105.8% FY 2024
Net Margin -11.0%
FY 2015: -114698.5%FY 2016: -35205.8%FY 2017: -39771.6%FY 2018: 0.0%FY 2019: -243713.7%FY 2020: -1007.5%FY 2021: -347.7%FY 2022: -102.9%FY 2023: -30.1%FY 2024: -11.0%
FY 2015 5y median -102.9% FY 2024
ROE -6.5%
FY 2015: -22.0%FY 2016: -31.0%FY 2017: -21.5%FY 2018: -48.8%FY 2019: -75.8%FY 2020: -34.6%FY 2021: -68.0%FY 2022: -39.1%FY 2023: -23.6%FY 2024: -6.5%
FY 2015 5y median -34.6% FY 2024
ROIC -10.0%
FY 2015: -22.1%FY 2016: -31.3%FY 2017: -22.2%FY 2018: -50.6%FY 2019: -70.6%FY 2020: -33.7%FY 2021: -64.4%FY 2022: -39.0%FY 2023: -26.2%FY 2024: -10.0%
FY 2015 5y median -33.7% FY 2024
ROA -5.5%
FY 2015: -21.6%FY 2016: -29.9%FY 2017: -20.7%FY 2018: -43.4%FY 2019: -58.8%FY 2020: -31.6%FY 2021: -58.0%FY 2022: -34.0%FY 2023: -19.2%FY 2024: -5.5%
FY 2015 5y median -31.6% FY 2024

Growth (YoY)

Revenue 46.6%
FY 2015: -84.2%FY 2016: 262.0%FY 2017: -25.7%FY 2018: -100.0%FY 2019: 0.0%FY 2020: 37071.5%FY 2021: 262.7%FY 2022: 204.9%FY 2023: 86.4%FY 2024: 46.6%
FY 2015 FY 2024
Operating Income 26.8%
FY 2015: -241.5%FY 2016: -11.8%FY 2017: 13.0%FY 2018: -57.8%FY 2019: 5.1%FY 2020: -50.1%FY 2021: -23.6%FY 2022: 7.7%FY 2023: 39.5%FY 2024: 26.8%
FY 2015 FY 2024
EPS (diluted) 50.7%
FY 2015: -172.0%FY 2016: 7.6%FY 2017: 21.2%FY 2018: -34.0%FY 2019: 5.6%FY 2020: -20.5%FY 2021: -8.4%FY 2022: 22.3%FY 2023: 46.3%FY 2024: 50.7%
FY 2015 FY 2024
Free Cash Flow 40.9%
FY 2015: -352.0%FY 2016: 11.5%FY 2017: 11.1%FY 2018: -46.0%FY 2019: -8.5%FY 2020: -79.0%FY 2021: -12.8%FY 2022: -4.3%FY 2023: 54.1%FY 2024: 40.9%
FY 2015 FY 2024

Financial Health

Current Ratio 6.4×
FY 2015: 77.2×FY 2016: 36.9×FY 2017: 33.0×FY 2018: 9.8×FY 2019: 6.4×FY 2020: 18.7×FY 2021: 8.8×FY 2022: 8.9×FY 2023: 5.4×FY 2024: 6.4×
FY 2015 5y median 8.8× FY 2024
Quick Ratio 6.2×
FY 2015: 77.2×FY 2016: 36.9×FY 2017: 33.0×FY 2018: 9.8×FY 2019: 6.4×FY 2020: 18.6×FY 2021: 8.6×FY 2022: 8.6×FY 2023: 5.3×FY 2024: 6.2×
FY 2015 5y median 8.6× FY 2024
Debt / Equity 0.0×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 44.7×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2015 5y median 0.0× FY 2024
Net Debt / EBITDA 2.5×
FY 2015: 0.5×FY 2016: 0.4×FY 2017: 0.4×FY 2018: 0.3×FY 2019: 0.6×FY 2020: 0.1×FY 2021: -65.3×FY 2022: 0.5×FY 2023: 0.8×FY 2024: 2.5×
FY 2015 5y median 0.5× FY 2024
Interest Coverage 0.0×
FY 2015: 0.0×FY 2016: -3215×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2015 5y median 0.0× FY 2024

Dividends

Dividend Yield 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31